Americans Feel Better About Saving for Retirement Than They Have in Years
A recent survey found that Americans are more confident about their retirement savings now than three years ago, before the current administration in Washington.
All Work
Chris Lange
What to Expect When Walgreens Reports Tuesday Morning
Walgreens Boots Alliance is scheduled to release its fiscal second-quarter financial results before the markets open on Tuesday.
SORL Auto Parts Revs Up After Q4
SORL Auto Parts released mixed fiscal fourth-quarter financial results before the markets opened on Monday.
Constellation Brands, GameStop, Walgreens and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Constellation Brands, GameStop, Walgreens and some of the other most anticipated earnings reports due this week.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a positive day for the broad U.S. markets. The S&P 500 and DJIA ultimately ended the week on a positive note after facing some slowdown in mid-March. The Lyft IPO also helped…
Lyft Enters the Market With a Bang
Lyft entered the market with a bang in one of the most anticipated IPO’s of the year. Shares actually entered the market at just over $87, compared to its pricing of $72, which was…
Amyris Wins Big With First Cannabinoid Milestone Payment
Amyris shares jumped on Friday after the firm announced that it has successfully delivered on its first milestone for its cannabinoid partner, Lavvan.
How DowDuPont Guidance Looks Ahead of the Split
DowDuPont shares dipped on Friday after the chemical giant provided an update for its modeling guidance for the first quarter of 2019.
How Hovnanian Plans to Stay Afloat in the NYSE
Hovnanian Enterprises is doing everything it can to stay listed on the New York Stock Exchange. It has executed the dreaded reverse stock split to keep its shares afloat on the index.
Where BlackBerry Can Go From Here
BlackBerry released better-than-expected fiscal fourth-quarter financial results before the markets opened on Friday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a positive day for the broad U.S. markets. The S&P 500 and DJIA bounced back from a surprisingly negative Wednesday, regaining the hope of ending the week with a gain. Crude oil…
What’s Next for Tricida’s Chronic Kidney Disease Treatment
Tricida shares jumped on Thursday after the firm announced results from its chronic kidney disease study.
Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?
Proteon Therapeutics shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with chronic kidney disease.
Lyft Raises the Stakes With Updated Pricing
On-demand ridesharing company Lyft expects to price more than 30 million shares to result in an initial public offering now valued up to over $2 billion.
Are Quantenna Shareholders Getting Enough in the Buyout?
There seems to be more consolidation within the semiconductor industry as ON Semiconductor has announced that it will be acquiring Quantenna Communications.
Why Amyris Could Break Out in April
Amyris shares ended Wednesday on a very positive note despite the broad markets lagging. The company reiterated guidance for its coming quarter as well as saying that it will discuss its future developments with…
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a down day for the broad U.S. markets. While the S&P 500 and DJIA started out positive, neither would be by the close. This comes after a very promising trading session on…
More and More Americans Worried About Financial Security
A recent financial security survey has found that many Americans remain anxious about their long-term financial security. The 2019 Primerica Financial Security Monitor found that many families are not taking steps toward a secure…
What to Expect When Lululemon Reports After the Close
Lululemon Athletica is scheduled to release its fiscal fourth-quarter results after the markets close on Wednesday.
What’s Next for Axsome Therapeutics After This FDA Approval
Axsome shares jumped on Wednesday after the firm gave an update from the FDA regarding its AXS-05 for the treatment of major depressive disorder.